Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Charlotte M. van Deuzen"'
Autor:
S Reshwan K Malahe, Rogier A S Hoek, Virgil A S H Dalm, Annoek E C Broers, Caroline M den Hoed, Olivier C Manintveld, Carla C Baan, Charlotte M van Deuzen, Grigorios Papageorgiou, Hannelore I Bax, Jeroen J Van Kampen, Merel E Hellemons, Marcia M L Kho, Rory D de Vries, Richard Molenkamp, Marlies E J Reinders, Bart J A Rijnders
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3):ciac571, e172-e178. Oxford University Press
Background Illness after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is less severe compared with previous variants. Data on the disease burden in immunocompromised patients are lacking. We investig
Autor:
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A.S.H. Dalm, Annoek E.C. Broers, Caroline M. den Hoed, Olivier C. Manintveld, Carla C. Baan, Charlotte M. van Deuzen, Grigorios Papageorgiou, Hannelore I. Bax, Jeroen J. Van Kampen, Merel E. Hellemons, Marcia M.L. Kho, Rory D. de Vries, Richard Molenkamp, Marlies E.J. Reinders, Bart J.A. Rijnders
BackgroundIn the general population, illness after infection with the SARS-CoV-2 Omicron variant is less severe compared with previous variants. Data on the disease burden of Omicron in immunocompromised patients are lacking. We investigated the clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9061f97ec953075968ede86cbbb2d29
https://doi.org/10.1101/2022.04.25.22273197
https://doi.org/10.1101/2022.04.25.22273197
Autor:
S Reshwan K, Malahe, Rogier A S, Hoek, Virgil A S H, Dalm, Annoek E C, Broers, Caroline M, den Hoed, Olivier C, Manintveld, Carla C, Baan, Charlotte M, van Deuzen, Grigorios, Papageorgiou, Hannelore I, Bax, Jeroen J, Van Kampen, Merel E, Hellemons, Marcia M L, Kho, Rory D, de Vries, Richard, Molenkamp, Marlies E J, Reinders, Bart J A, Rijnders
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
In the general population, illness after infection with the SARS-CoV-2 Omicron variant is less severe compared with previous variants. Data on the disease burden of Omicron in immunocompromised patients are lacking. We investigated the clinical chara